Please login to the form below
sexual dysfunction
This page shows the latest sexual dysfunction news and features for those working in and with pharma, biotech and healthcare.
FDA panel backs Sprout Pharma's 'female Viagra'
The panel voted by 18 to 6 that the drug - called flibanserin - should be approved to treat hypoactive sexual desire disorder (HSDD) in pre-menopausal women, opening the door for a ... However, the committee said that given the intended use of the drug
Latest news
-
Lundbeck launches Brintellix in first EU market
Clinical trial results suggest Brintellix is at least as effective as Lexapro in adult patients with major depressive disorders and is significantly less likely to cause sexual dysfunction, a common problem
-
Menarini to raise awareness of sexual dysfunction
The rugby player ambassadors of Menarini's sexual dysfunction campaign. Italian pharma company A. ... Menarini Farmaceutica Internazionale has launched a campaign to address poor awareness of sexual dysfunction in the UK.
-
Female sexual dysfunction therapy pipeline
Female sexual dysfunction (FSD) pertains to persistent or recurrent problems with sexual response or desire in women. ... Both physical and psychosocial factors may be implicated in sexual dysfunction, although the exact cause cannot always be identified.
-
Making a big splash
Whether you are treating heart disease or sexual dysfunction, the biggest competitor we face is often doing nothing.
-
It's all in the detail
Defined by specific diseases, eg, psoriasis, rheumatoid arthritis, erectile dysfunction, etc, these groups will often discuss the topic in an oblique way. ... For example, erectile dysfunction conversations are often around sexual self-confidence, which
More from news
Approximately 1 fully matching, plus 25 partially matching documents found.
Latest Intelligence
-
Deal Watch February 2017
Acquisition - business unit. 1, 045. EndoCeutics/ AMAG Pharmaceuticals. Intraros (prasterone), non-oestrogen product for postmenopausal atrophic vaginitis (FDA approved), female sexual dysfunction (phase III).
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Client Services Director - Med Comms
-
Great salary and bebefits
Subscribe to our email news alerts
- Brexit rebels win vote on European Medicines Agency alignment
- AstraZeneca joins Merck in Brexit stockpiling effort
- NHS England to Vertex: come clean on Orkambi offer
- Moving annual total (MAT)
- Vyriad inks immunotherapy alliance with Merck/Pfizer
- J&J’s Invokana aces diabetic kidney disease trial, setting up filings
- Love Island ads fuel body image problems, warn health leaders
- Daily Brief: Janssen's HIV vaccine, Q3 results, Biogen's Alzheimer's data
- Shining brighter than ever
- China’s BeiGene takes PD-1 antibody into pivotal trials
- Sangamo bulks up in cell therapy with TxCell acquisition
- Random42 win Creativity International Award for Scientific Animation
PMHub
SpotMe
SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
